GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (NAS:IDXX) » Definitions » Price-to-Free-Cash-Flow

IDEXX Laboratories (IDEXX Laboratories) Price-to-Free-Cash-Flow : 53.15 (As of Apr. 25, 2024)


View and export this data going back to 1991. Start your Free Trial

What is IDEXX Laboratories Price-to-Free-Cash-Flow?

As of today (2024-04-25), IDEXX Laboratories's share price is $489.24. IDEXX Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $9.21. Hence, IDEXX Laboratories's Price-to-Free-Cash-Flow Ratio for today is 53.15.

The historical rank and industry rank for IDEXX Laboratories's Price-to-Free-Cash-Flow or its related term are showing as below:

IDXX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 28.6   Med: 63.55   Max: 109.02
Current: 53.14

During the past 13 years, IDEXX Laboratories's highest Price-to-Free-Cash-Flow Ratio was 109.02. The lowest was 28.60. And the median was 63.55.

IDXX's Price-to-Free-Cash-Flow is ranked worse than
75.82% of 91 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.41 vs IDXX: 53.14

IDEXX Laboratories's Free Cash Flow per Share for the three months ended in Dec. 2023 was $2.59. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $9.21.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of IDEXX Laboratories was 102.70% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 13.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 19.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 18.90% per year.

During the past 13 years, IDEXX Laboratories's highest 3-Year average Free Cash Flow per Share Growth Rate was 98.80% per year. The lowest was -43.50% per year. And the median was 18.65% per year.


IDEXX Laboratories Price-to-Free-Cash-Flow Historical Data

The historical data trend for IDEXX Laboratories's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Price-to-Free-Cash-Flow Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 75.21 80.25 89.64 89.84 60.31

IDEXX Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.84 92.23 71.15 54.00 60.31

Competitive Comparison of IDEXX Laboratories's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, IDEXX Laboratories's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Price-to-Free-Cash-Flow falls into.



IDEXX Laboratories Price-to-Free-Cash-Flow Calculation

IDEXX Laboratories's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=489.24/9.205
=53.15

IDEXX Laboratories's Share Price of today is $489.24.
IDEXX Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.21.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

IDEXX Laboratories  (NAS:IDXX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


IDEXX Laboratories Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (IDEXX Laboratories) Business Description

Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.
Executives
James F Polewaczyk officer: Corporate Vice President IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan Jay Mazelsky director, officer: President and CEO ONE IDEXX DRIVE, WESTBROOK ME 04092
Martin Alexander Smith officer: Executive Vice President C/O IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan W Ayers director, officer: President & CEO IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Michael Lane officer: Executive Vice President C/O IDEXX LABORATORIES, INC., WESTBROOK ME 04092
Irene Chang Britt director CAMPBELL SOUP COMPANY, ONE CAMPBELL PLACE, CAMDEN NJ 08103
Bruce L. Claflin director 7035 RIDGE ROAD, HANOVER MD 21076
Samer Abdul Samad director 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Lawrence D Kingsley director C/O IDEX CORPORATION, 630 DUNDEE ROAD, NORTHBROOK IL 60062
Asha Collins director IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
M Anne Szostak director C/O TUPPERWARE BRANDS CORP, 14901 S ORANGE BLOSSOM TR, ORLANDO FL 32837
Sharon E. Underberg officer: EVP, GC & Corporate Secretary EASTMAN KODAK COMPANY, 343 STATE STREET, ROCHESTER NY 14650
Sophie V. Vandebroek director 6 OAK MEADOW ROAD, LINCOLN MA 01770
Daniel M Junius director C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451

IDEXX Laboratories (IDEXX Laboratories) Headlines